Philadelphia Institute of Dermatology

The Philadelphia Institute of Dermatology is a specialized clinical research organization focused on conducting Phase I through IV clinical trials in the field of dermatology. Founded by the renowned dermatologist Dr. Albert Kligman, the institute has a long history of contributing to the development of significant skin treatments, including tretinoin (Retin-A). Today, it operates as a key facility within the Synexus clinical research network, a subsidiary of PPD and Thermo Fisher Scientific. The institute partners with global pharmaceutical and biotechnology companies to evaluate the safety and efficacy of new skin treatments and aesthetic products, providing high-quality data and efficient patient recruitment for a wide range of dermatological indications.